Defining a Test for HER-2/neu Evaluation in Breast Cancer in the Diagnostic Setting
Authors:
- 1 July 2001
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 14 (7) , 677-685
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Testing for erbB-2 by Immunohistochemistry in Breast CancerAmerican Journal of Clinical Pathology, 2000
- Determination of Her-2/Neu Status in Breast Carcinoma: Comparative Analysis of Immunohistochemistry and Fluorescent In Situ HybridizationLaboratory Investigation, 2000
- Quantitative PCR analysis of c-erb B-2 (HER2/neu) gene amplification and comparison with p185HER2/neu protein expression in breast cancer drill biopsiesInternational Journal of Cancer, 1999
- The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for TherapyStem Cells, 1998
- erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast CancerJNCI: Journal of the National Cancer Institute, 1998
- erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast CancerJNCI: Journal of the National Cancer Institute, 1998
- erbB-2 Oncoprotein Expression in Breast Carcinoma:Poor Prognosis Associated With High Degree of Cytoplasmic Positivity Using CB-11 AntibodyAmerican Journal of Clinical Pathology, 1997
- The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cellsOncogene, 1997
- Use of Methodological Standards in Diagnostic Test ResearchJAMA, 1995
- Optimization of immunohistochemical detection of ERBB2 in human breast cancer: Impact of fixationThe Journal of Pathology, 1994